Matter-Walstra, Klazien and Joerger, Markus and Kühnel, Ursula and Szucs, Thomas and Pestalozzi, Bernhard and Schwenkglenks, Matthias. (2012) Cost-effectiveness of maintenance pemetrexed in patients with advanced nonsquamous-cell lung cancer from the perspective of the swiss health care system. Value in health, Vol. 15, H. 1. pp. 65-71.
Full text not available from this repository.
Official URL: http://edoc.unibas.ch/dok/A6007019
Downloads: Statistics Overview
Abstract
A recent randomized study showed switch maintenance with pemetrexed after nonpemetrexed-containing first-line chemotherapy in patients with advanced nonsmall-cell lung cancer to prolong overall survival by 2.8 months. We examined the cost-effectiveness of pemetrexed in this indication, from the perspective of the Swiss health care system, and assessed the influence of the costs of best supportive care (BSC) on overall cost-effectiveness.
| Faculties and Departments: | 03 Faculty of Medicine > Departement Public Health > Pharmazeutische Medizin ECPM > Pharmazeutische Medizin (Szucs) |
|---|---|
| UniBasel Contributors: | Schwenkglenks, Matthias and Matter-Walstra, Klazien Wietske |
| Item Type: | Article, refereed |
| Article Subtype: | Research Article |
| Publisher: | Elsevier |
| ISSN: | 1098-3015 |
| Note: | Publication type according to Uni Basel Research Database: Journal article |
| Last Modified: | 24 May 2013 09:14 |
| Deposited On: | 26 Apr 2013 06:59 |
Repository Staff Only: item control page